Literature DB >> 32737653

Presentation outside office hours does not negatively influence treatment times for reperfusion therapy for acute ischemic stroke.

A E Groot1, H de Bruin1, T T M Nguyen2, M Kappelhof3, F de Beer4, M C Visser5, C P Zwetsloot6, P H A Halkes7, J de Kruijk8, W D M van der Meulen9, T C van der Ree10, V I H Kwa11, S M van Schaik12, L Hani13, R van den Berg3, M E S Sprengers3, S D Roosendaal3, B J Emmer3, P J Nederkoorn1, C B L M Majoie3, Y B W E M Roos1, J M Coutinho14.   

Abstract

BACKGROUND: Treatment outside office hours has been associated with increased workflow times for intravenous thrombolysis (IVT) in acute ischemic stroke (AIS). Limited data suggest that this "off-hours effect" also exists for endovascular treatment (EVT). We investigated this phenomenon in a well-organized acute stroke care region in the Netherlands.
METHODS: Retrospective, observational cohort study of consecutive patients with AIS who received reperfusion therapy in the Greater Amsterdam Area, consisting of 14 primary stroke centers and 1 comprehensive stroke center (IVT: 2009-2015, EVT: 2014-2017). Office hours were defined as presentation during weekdays between 8 AM and 5 PM, excluding National Festive days. Primary outcome was door-to-treatment time (door-to-needle [DNT] for IVT, door-to-groin [DGT] for EVT). For DGT, we used the door time of the first hospital. Other outcomes were in-hospital mortality, modified Rankin Scale (mRS) score at 90 days and symptomatic intracranial hemorrhage (sICH). We performed multivariable linear and logistic regression analyses and used multiple imputation to account for missing values.
RESULTS: In total, 59% (2450/4161) and 61% (239/395) of patients treated with IVT and EVT, respectively, presented outside office hours. Median DNT was minimally longer outside office hours (32 vs. 30 min, p = 0.024, adjusted difference 2.5 min, 95% CI 0.7-4.2). Presentation outside office hours was not associated with a longer DGT (median 130 min for both groups, adjusted difference 7.0 min, 95% CI - 4.2 to 18.1). Clinical outcome and sICH rate also did not differ.
CONCLUSION: Presentation outside office hours did not lead to clinically relevant treatment delays for reperfusion therapy in patients with AIS.

Entities:  

Keywords:  Acute ischemic stroke; Functional outcome; Off-hour presentation; Treatment times; Workflow

Mesh:

Year:  2020        PMID: 32737653      PMCID: PMC7815598          DOI: 10.1007/s00415-020-10106-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  1 in total

1.  Endovascular stroke therapy at nighttime and on weekends-as fast and effective as during normal business hours?

Authors:  Anastasios Mpotsaris; Annika Kowoll; Werner Weber; Christoph Kabbasch; Anushe Weber; Daniel Behme
Journal:  J Vasc Interv Neurol       Date:  2015-02
  1 in total
  3 in total

1.  Workflow Intervals and Outcomes of Endovascular Treatment for Acute Large-Vessel Occlusion During On-Vs. Off-hours in China: The ANGEL-ACT Registry.

Authors:  Yunlong Ding; Feng Gao; Yong Ji; Tingting Zhai; Xu Tong; Baixue Jia; Jian Wu; Jiaqi Wu; Yanrong Zhang; Can Wei; Wenjuan Wang; Jue Zhou; Jiali Niu; Zhongrong Miao; Yan Liu
Journal:  Front Neurol       Date:  2021-12-21       Impact factor: 4.003

2.  Advancement of door-to-needle times in acute stroke treatment after repetitive process analysis: never give up!

Authors:  Johanna Ernst; Kai F Storch; Anh Thu Tran; Maria M Gabriel; Andrei Leotescu; Anna-Lena Boeck; Meret K Huber; Omar Abu-Fares; Paul Bronzlik; Friedrich Götz; Hans Worthmann; Ramona Schuppner; Gerrit M Grosse; Karin Weissenborn
Journal:  Ther Adv Neurol Disord       Date:  2022-09-15       Impact factor: 6.430

3.  Off-hour effect is not significant in endovascular treatment for anterior circulation large vessel occlusion in a multicentre registry.

Authors:  Mingming Zha; Qingwen Yang; Shuo Liu; Dong Yang; Xinfeng Liu; Kangmo Huang; Xiaohao Zhang; Min Wu; Haodi Cai; Qiushi Lv; Rui Liu
Journal:  Stroke Vasc Neurol       Date:  2021-07-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.